-
1
-
-
0025256091
-
Amphotericin B: 30 years of clinical experience
-
Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12(2):308-329.
-
(1990)
Rev Infect Dis
, vol.12
, Issue.2
, pp. 308-329
-
-
Gallis, H.A.1
Drew, R.H.2
Pickard, W.W.3
-
2
-
-
0031895240
-
Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate
-
Garnacho-Montero J, Ortiz-Leyba C, Garcia Garmendia JL, Jimenez F. Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate. Clin Infect Dis. 1998;26(4):1016.
-
(1998)
Clin Infect Dis
, vol.26
, Issue.4
, pp. 1016
-
-
Garnacho-Montero, J.1
Ortiz-Leyba, C.2
Garcia Garmendia, J.L.3
Jimenez, F.4
-
3
-
-
17344368128
-
Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
-
Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998;26(6):1383-1396.
-
(1998)
Clin Infect Dis
, vol.26
, Issue.6
, pp. 1383-1396
-
-
Walsh, T.J.1
Hiemenz, J.W.2
Seibel, N.L.3
-
4
-
-
0033396524
-
Amphotericin B lipid complex (ABLC)-associated hypertension: Case report and review
-
Rowles DM, Fraser SL. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review. Clin Infect Dis. 1999;29(6):1564-1565.
-
(1999)
Clin Infect Dis
, vol.29
, Issue.6
, pp. 1564-1565
-
-
Rowles, D.M.1
Fraser, S.L.2
-
5
-
-
0030703608
-
Hypertension exacerbated by amphotericin B administration
-
Ferreira E, Perreault MM. Hypertension exacerbated by amphotericin B administration. Ann Pharmacother. 1997;31(11):1407-1408.
-
(1997)
Ann Pharmacother
, vol.31
, Issue.11
, pp. 1407-1408
-
-
Ferreira, E.1
Perreault, M.M.2
-
6
-
-
0030016094
-
Amphotericin B-associated hypertension
-
Le Y, Rana KZ, Dudley MN. Amphotericin B-associated hypertension. Ann Pharmacother. 1996;30(7-8):765-767.
-
(1996)
Ann Pharmacother
, vol.30
, Issue.7-8
, pp. 765-767
-
-
Le, Y.1
Rana, K.Z.2
Dudley, M.N.3
-
8
-
-
0028145480
-
Amphotericin B and hypertension
-
Katz BZ, Cohn RA. Amphotericin B and hypertension. Pediatr Infect Dis J. 1994;13(9):839-840.
-
(1994)
Pediatr Infect Dis J
, vol.13
, Issue.9
, pp. 839-840
-
-
Katz, B.Z.1
Cohn, R.A.2
-
9
-
-
0025248870
-
Amphotericin B-induced malignant hypertensive episodes
-
Dukes CS, Perfect JR. Amphotericin B-induced malignant hypertensive episodes. J Infect Dis. 1990;161(3):588.
-
(1990)
J Infect Dis
, vol.161
, Issue.3
, pp. 588
-
-
Dukes, C.S.1
Perfect, J.R.2
-
10
-
-
0026014634
-
Direct vasoconstriction as possible cause for amphotericin B-induced nephrotoxicity in rats
-
Sawaya BP, Weihprecht H, Campbell WR, et al. Direct vasoconstriction as possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest. 1991;87(6):2097-2107.
-
(1991)
J Clin Invest
, vol.87
, Issue.6
, pp. 2097-2107
-
-
Sawaya, B.P.1
Weihprecht, H.2
Campbell, W.R.3
-
11
-
-
24144465716
-
Strategies for managing systemic fungal infection and the place of itraconazole
-
Potter M. Strategies for managing systemic fungal infection and the place of itraconazole. J Antimicrob Chemother. 2005;56(suppl 1):i49-i54.
-
(2005)
J Antimicrob Chemother
, vol.56
, Issue.1 SUPPL.
-
-
Potter, M.1
|